Notice NOT-AI-18-009 from the NIH Guide for Grants and Contracts

Notice NOT-HL-18-573 from the NIH Guide for Grants and Contracts

Notice NOT-HL-18-574 from the NIH Guide for Grants and Contracts

Notice NOT-HL-18-575 from the NIH Guide for Grants and Contracts

Notice NOT-HL-18-576 from the NIH Guide for Grants and Contracts

Notice NOT-HL-18-577 from the NIH Guide for Grants and Contracts

Notice NOT-HL-18-578 from the NIH Guide for Grants and Contracts

Notice NOT-OD-18-126 from the NIH Guide for Grants and Contracts

Notice NOT-HL-17-572 from the NIH Guide for Grants and Contracts

Notice NOT-OD-18-124 from the NIH Guide for Grants and Contracts

Data science, machine learning, data mining, data-intensive computing, large-scale database architecture, computational statistics, network analysis, time...
From Institute for Systems Biology - Fri, 12 Jan 2018 09:21:10 GMT - View all Seattle, WA jobs

Funding Opportunity PAR-18-582 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that expand on foundational research demonstrating generally improved emotional function and emotion regulation with aging, to further clarify the trajectories of change in emotion processing and linked neurobiological factors in adults who are aging normally, as well as in individuals with mild cognitive impairment (MCI), Alzheimer's disease, and related dementias (ADRD). The goal is three-fold: to advance understanding of (1) normative maturational shifts in emotional processes, (2) how dysfunction in the integrative neural-behavioral mechanisms of emotional function might manifest in MCI and the early stages of ADRD, and/or (3) how such dysfunction might account for any of the neuropsychiatric symptoms observed in ADRD. Such studies may identify novel targets for interventions or prevention efforts, or provide clues to intervention strategies that might be applied to normalize emotion dysregulation or strengthen emotional resilience at different life stages in normal aging or disease stages in MCI and ADRD. The R21 Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects.

Funding Opportunity PAR-18-581 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that expand on foundational research demonstrating generally improved emotional function and emotion regulation with aging, to further clarify the trajectories of change in emotion processing and linked neurobiological factors in adults who are aging normally, as well as in individuals with mild cognitive impairment (MCI), Alzheimer's disease, and related dementias (ADRD). The goal is three-fold: to advance understanding of (1) normative maturational shifts in emotional processes, (2) how dysfunction in the integrative neural-behavioral mechanisms of emotional function might manifest in MCI and the early stages of ADRD, and/or (3) how such dysfunction might account for any of the neuropsychiatric symptoms observed in ADRD. Such studies may identify novel targets for interventions or prevention efforts, or provide clues to intervention strategies that might be applied to normalize emotion dysregulation or strengthen emotional resilience at different life stages in normal aging or disease stages in MCI and ADRD. This FOA invites Stage 0 (basic research) or Stage I (intervention development/modification) clinical trials, in line with the NIH Stage Model.

Funding Opportunity PA-18-566 from the NIH Guide for Grants and Contracts. The overarching goal of the SBIR program at the National Institute of Mental Health (NIMH) is to support small businesses to develop technologies that can advance the mission of the Institute, including in basic neuroscience research relevant to mental disorders, translational and clinical research of mental disorders, clinical diagnosis or treatment of mental disorders, and dissemination of evidence-based mental health care. This FOA encourages SBIR grant applications to support research and development of particular priority research topics - complex technologies that require funding levels and durations beyond those reflected in the standard SBIR guidelines.

Funding Opportunity PA-18-579 from the NIH Guide for Grants and Contracts. The overarching goal of the SBIR program at the National Institute of Mental Health (NIMH) is to support small businesses to develop technologies that can advance the mission of the Institute, including in basic neuroscience research relevant to mental disorders, translational and clinical research of mental disorders, clinical diagnosis or treatment of mental disorders, and dissemination of evidence-based mental health care. This FOA encourages SBIR grant applications to support research and development of particular priority research topics - complex technologies that require funding levels and durations beyond those reflected in the standard SBIR guidelines.

Funding Opportunity RFA-HS-18-001 from the NIH Guide for Grants and Contracts. This R18 Request for Application (RFA) calls for the creation and utilization of Patient Safety Learning Laboratories. These learning laboratories are places and networks where transdisciplinary teams identify closely related threats to diagnostic or treatment efforts associated with a high burden of harm and cost. Following a systems engineering methodology, the learning laboratories stretch professional boundaries, envision innovative designs, and take advantage of brainstorming and rapid prototyping techniques that other leading industries employ. Promising prototypes undergo further develop-test-revise iterations, and subsequent integration as a working system. After further improvements are made to the integrated working system, its efficacy is evaluated in a realistic simulated or clinical setting. While applicants will select the area of diagnostic or treatment focus they consider of high significance, a flexible methodology -- problem analysis, design, development, implementation, and evaluation -- is required that parallels a systems engineering process to give an underlying structure to the work undertaken. In addition to longer-recognized patient safety issues, AHRQ also recognizes the importance of addressing harms caused by diagnostic failure. As a consequence, applications that address the diagnostic as well as the treatment sides of medicine are welcomed.

Funding Opportunity PAR-18-577 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite grant applications to establish new and innovative epidemiology cohort studies that will prospectively follow at least 2,000 participants and are designed to study a wide range of research hypotheses related to heart, lung, blood, and/or sleep phenotypes. Through this FOA, the National Heart, Lung, and Blood Institute (NHLBI) will support activities required to establish a new cohort, including identification and recruitment of cohort participants, detailed baseline data collection on all participants, biospecimen collection and storage, study infrastructure, and data quality control and analysis.

Research interests of current Biostatistics faculty include GWAS , statistical genetics, pharmacogenomics, public health bioinformatics, survival analysis,...
From University of Wisconsin–Milwaukee - Thu, 11 Jan 2018 22:18:54 GMT - View all Milwaukee, WI jobs

Negotiable: Paramount Recruitment: Bioinformatics Analyst A fantastic opportunity has become available for a talented Bioinformatics Analyst to join some of the world's brightest minds at one of the country's most influential Biotechs. Headquartered at an idyllic location in Cambridge, Cambridge, England

Funding Opportunity PA-18-571 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites pilot/feasibility projects that propose basic, clinical, or translational research on underactive bladder (UAB) and detrusor underactivity (DU) and its consequences in aging and in older persons. Applications should focus on the 1) biology, etiology and pathophysiology of DU or UAB in animal models and/or older adults; 2) translation of basic/clinical research into clinical practice and health decision-making; 3) diagnosis, prevention, management and clinical outcomes of UAB in older adults; and/or 4) epidemiology and risk factors for the development of DU/UAB with advancing age. Pilot/feasibility research supported by this initiative should enhance knowledge of DU/UAB and its consequences in older adults and provide evidence-based guidance in the diagnosis, evaluation, and treatment of DU/UAB in older persons.